The latest research – in brief
Phoebe Harkin | | Quick Read
1. Communication between the eye and the brain is clearly critical to our sense of sight. But the exact molecular mechanisms have been a source of speculation – until now. Using advanced mass spectrometry, a team at Scripps Research Institute has discovered how visual signals are distributed throughout the brain. The team identified upwards of 1,000 protein types that originate in the eye’s retinal ganglion cells. They then watched how – and where – they traveled via the optic nerve in a living brain of a rat. The team evaluated the two major targets: the superior colliculus, which analyzes motion, and the lateral geniculate nucleus, which sends information to the visual cortex. Researchers found that similar proteins didn’t always share a common destination, rather, many proteins were transported preferentially to one brain region, while some were transported to all of the regions studied. Though still in its infancy, the study expands accepted understanding of the visual system and, according to researchers, will hopefully lead to enhanced treatments in the future. Watch this space.
2. A collaboration between the University of Geneva and the École Polytechnique Fédérale de Lausanne may have answered the most fundamental question in ophthalmology: how is the retina formed? Sequencing more than 6,000 cells during embryonic development, the researchers did more than just uncover how – and why – certain neurons become associated with certain parts of the visual system; by predicting the sequential activation of neural genes, the team were able to reconstruct several differentiation programs, similar to lineage trees, showing how the progenitors progress to one cell type or another after their last division. They then conducted a secondary analysis, comparing the genetic diversity of two neuron populations – those associated with the left and right eye – discovering 24 genes that could play a key role in three-dimensional vision. The team hopes to continue their research, explaining that the more we know about the molecules needed to appropriately guide axons, the more likely we are to develop a therapy to treat nerve trauma.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.